Metropolis Healthcare reports strong Q1FY27 performance, with revenue up 17% to ₹450 crore and EBITDA up 27% YoY

▴ Metropolis Healthcare
Ameera Shah-led Metropolis Healthcare Limited , India’s second-largest and the most respected pathology laboratory chain, today announced its unaudited consolidated financial results for the quarter ended June 30th, 2026.

Mumbai, India, 4th August 2026: Ameera Shah-led Metropolis Healthcare Limited (NSE: METROPOLIS | BSE: 542650), India’s second-largest and the most respected pathology laboratory chain, today announced its unaudited consolidated financial results for the quarter ended June 30th, 2026.

 

Q1FY27 – Financial & Operational Highlights:

 

  • Patient volume grew 10% YoY, while test volume increased 11% YoY, reflecting sustained demand, deeper market penetration and the continued shift towards trusted diagnostic chains
  • B2C revenue grew 18% YoY, driven by strong brand pull, targeted micro-marketing and expanding digital engagement. B2B revenue increased 15% YoY, supported by improving business quality and a broader clinician and institutional network
  • TruHealth revenue grew 22% YoY to INR 81 crore (18% of segment mix), while Specialty revenue increased 17% YoY to INR 178 crore (40% of segment mix), strengthening the portfolio mix. Premium TruHealth packages grew over 50%, while radiology-integrated wellness packages increased by more than 40%
  • Revenue per Patient (RPP) increased 6% YoY, while Revenue per Test (RPT) improved 5% YoY, supported by a richer test mix and higher contribution from specialised diagnostics
  • Tier III cities remained the fastest-growing markets, with revenue increasing around 25% YoY, compared with 11% growth in Tier I and 14% in Tier II, highlighting the significant growth opportunity beyond large metros

 

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026